| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.36 | 8e-06 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0008 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |